Jindong Sheng
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Urology top 10%
- Urinary Bladder and Prostate Research
Papers in
-
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 3
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Baoguo Liu (4 shared papers)Jie Jin (6 shared papers)Zheming Lu (3 shared papers)Wei Yu (4 shared papers)Qun He (4 shared papers)Yun Cui (4 shared papers)Yu Fan (5 shared papers)Fangxuan Li (2 shared papers)
- Journals
- PLoS ONE (2 papers)Oncotarget (2 papers)Journal of Cellular and Molecular Medicine (2 papers)Cell Death and Disease (2 papers)The Prostate (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jindong Sheng
17 papers receiving 413 citations
Peers
Comparison fields: 5 of 57
- Endocrinology, Diabetes and Metabolism 98
- Urology 26
- Cancer Research 57
- Immunology 61
- Pulmonary and Respiratory Medicine 87
Countries citing papers authored by Jindong Sheng
This map shows the geographic impact of Jindong Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jindong Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jindong Sheng more than expected).
Fields of papers citing papers by Jindong Sheng
This network shows the impact of papers produced by Jindong Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jindong Sheng. The network helps show where Jindong Sheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jindong Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 59 | |
| 2 | 2019 | 40 | |
| 3 | 2018 | 39 | |
| 4 | 2022 | 38 | |
| 5 | 2017 | 36 | |
| 6 | 2014 | 34 | |
| 7 | 2022 | 33 | |
| 8 | 2021 | 29 | |
| 9 | 2021 | 24 | |
| 10 | 2017 | 20 | |
| 11 | 2016 | 18 | |
| 12 | 2017 | 15 | |
| 13 | 2019 | 14 | |
| 14 | 2024 | 8 | |
| 15 | 2024 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2022 | 3 |
About Jindong Sheng
Jindong Sheng is a scholar working on Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Urology, having authored 17 papers that have together received 417 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Hormonal and reproductive studies (3 papers), Urinary Bladder and Prostate Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer-related gene regulation (3 papers), Prostate Cancer Treatment and Research (2 papers), Immunotherapy and Immune Responses (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (98 citations), Urology (26 citations), Cancer Research (57 citations), Immunology (61 citations) and Pulmonary and Respiratory Medicine (87 citations). Jindong Sheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Baoguo Liu, Jie Jin, Zheming Lu, Wei Yu, Qun He, Yun Cui, Yu Fan, Fangxuan Li, Wenke Han and Shuai Hu. Their work appears in journals such as PLoS ONE, Oncotarget, Journal of Cellular and Molecular Medicine, Cell Death and Disease and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.